Intellia's (NTLA) Q1 Earnings & Revenues Beat Estimates [Yahoo! Finance]
Intellia Therapeutics, Inc. (NTLA)
Last intellia therapeutics, inc. earnings: 2/27 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.intelliatx.com/investor-overview
Company Research
Source: Yahoo! Finance
In the year-ago quarter, Intellia incurred a loss of $1.17 per share. The reported loss excluded a one-time expense of change in fair value of investments, net, including which the company reported a loss of $1.12 per share in the first quarter of 2024. The company's total revenues currently comprise only collaboration revenues. NTLA reported revenues of $28.9 million for the first quarter of 2024 compared with $12.6 million reported in the year-ago quarter. The year-over-year increase in revenues was due to a $21 million non-cash revenue recognition adjustment related to the AvenCell collaboration. The top line beat the Zacks Consensus Estimate of $16 million. Shares of Intellia were up 8.1% on May 9 following the announcement of the better-than-expected results. However, the stock has decreased 18.4% year to date compared with the industry's decline of 6.2%. Image Source: Zacks Investment Research Quarter in Details Intellia's collaboration revenues also beat our model
Show less
Read more
Impact Snapshot
Event Time:
NTLA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NTLA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NTLA alerts
High impacting Intellia Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
NTLA
News
- Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought [Yahoo! Finance]Yahoo! Finance
- Intellia Therapeutics, Inc. (NTLA) Just Overtook the 50-Day Moving Average [Yahoo! Finance]Yahoo! Finance
- Earnings Beat: Intellia Therapeutics, Inc. (NASDAQ:NTLA) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts [Yahoo! Finance]Yahoo! Finance
- Intellia Therapeutics, Inc. (NASDAQ: NTLA) was upgraded by analysts at StockNews.com to a "sell" rating.MarketBeat
- Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Citigroup Inc. from $31.00 to $29.00. They now have a "neutral" rating on the stock.MarketBeat
NTLA
Earnings
- 5/9/24 - Beat
NTLA
Sec Filings
- 5/9/24 - Form 10-Q
- 5/9/24 - Form 8-K
- 4/29/24 - Form ARS
- NTLA's page on the SEC website